58 related articles for article (PubMed ID: 25139413)
21. Differential requirements for β-catenin in murine prostate cancer originating from basal versus luminal cells.
Lu TL; Chen CM
J Pathol; 2015 Jul; 236(3):290-301. PubMed ID: 25712462
[TBL] [Abstract][Full Text] [Related]
22. Methodological aspects of the molecular and histological study of prostate cancer: focus on PTEN.
Ugalde-Olano A; Egia A; Fernández-Ruiz S; Loizaga-Iriarte A; Zuñiga-García P; Garcia S; Royo F; Lacasa-Viscasillas I; Castro E; Cortazar AR; Zabala-Letona A; Martín-Martín N; Arruabarrena-Aristorena A; Torrano-Moya V; Valcárcel-Jiménez L; Sánchez-Mosquera P; Caro-Maldonado A; González-Tampan J; Cachi-Fuentes G; Bilbao E; Montero R; Fernández S; Arrieta E; Zorroza K; Castillo-Martín M; Serra V; Salazar E; Macías-Cámara N; Tabernero J; Baselga J; Cordón-Cardo C; Aransay AM; Villar AD; Iovanna JL; Falcón-Pérez JM; Unda M; Bilbao R; Carracedo A
Methods; 2015 May; 77-78():25-30. PubMed ID: 25697760
[TBL] [Abstract][Full Text] [Related]
23. Kinases, tails and more: regulation of PTEN function by phosphorylation.
Fragoso R; Barata JT
Methods; 2015 May; 77-78():75-81. PubMed ID: 25448482
[TBL] [Abstract][Full Text] [Related]
24. Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors.
Chen EJ; Sowalsky AG; Gao S; Cai C; Voznesensky O; Schaefer R; Loda M; True LD; Ye H; Troncoso P; Lis RL; Kantoff PW; Montgomery RB; Nelson PS; Bubley GJ; Balk SP; Taplin ME
Clin Cancer Res; 2015 Mar; 21(6):1273-80. PubMed ID: 25320358
[TBL] [Abstract][Full Text] [Related]
25. Silence of PTEN in colorectal cancer cells via siRNA inhibits cell growth.
Chen ZX; Sang QT; Du YG; Xin YY
J Environ Pathol Toxicol Oncol; 2014; 33(3):233-7. PubMed ID: 25272061
[TBL] [Abstract][Full Text] [Related]
26. Prostate cancer: radioresistance molecular target-related markers and foreseeable modalities of radiosensitization.
Alberti C
Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2275-82. PubMed ID: 25219826
[TBL] [Abstract][Full Text] [Related]
27. Targeting PI3K/Akt signaling in prostate cancer therapy.
Hashemi M; Taheriazam A; Daneii P; Hassanpour A; Kakavand A; Rezaei S; Hejazi ES; Aboutalebi M; Gholamrezaie H; Saebfar H; Salimimoghadam S; Mirzaei S; Entezari M; Samarghandian S
J Cell Commun Signal; 2023 Sep; 17(3):423-443. PubMed ID: 36367667
[TBL] [Abstract][Full Text] [Related]
28. ARRDC4 and UBXN1: Novel Target Genes Correlated with Prostate Cancer Gleason Score.
Oh JJ; Ho JN; Byun SS
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680357
[TBL] [Abstract][Full Text] [Related]
29. Comparative Cytotoxic Activity of Hydroxytyrosol and Its Semisynthetic Lipophilic Derivatives in Prostate Cancer Cells.
León-González AJ; Sáez-Martínez P; Jiménez-Vacas JM; Herrero-Aguayo V; Montero-Hidalgo AJ; Gómez-Gómez E; Madrona A; Castaño JP; Espartero JL; Gahete MD; Luque RM
Antioxidants (Basel); 2021 Aug; 10(9):. PubMed ID: 34572980
[TBL] [Abstract][Full Text] [Related]
30. miR-26b regulates cell proliferation and apoptosis of CD117+CD44+ ovarian cancer stem cells by targeting PTEN.
Gao Z; Ye X; Bordeaux A; Hettich S; Lin S; Han F; Jia Y
Eur J Histochem; 2021 Feb; 65(1):. PubMed ID: 33634678
[TBL] [Abstract][Full Text] [Related]
31. Estrogen Receptor Signaling Pathways Involved in Invasion and Colony Formation of Androgen-Independent Prostate Cancer Cells PC-3.
Lombardi APG; Cavalheiro RP; Porto CS; Vicente CM
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503805
[TBL] [Abstract][Full Text] [Related]
32. Nuclear Heparanase Regulates Chromatin Remodeling, Gene Expression and PTEN Tumor Suppressor Function.
Amin R; Tripathi K; Sanderson RD
Cells; 2020 Sep; 9(9):. PubMed ID: 32899927
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA 26b promotes colorectal cancer metastasis by downregulating phosphatase and tensin homolog and wingless-type MMTV integration site family member 5A.
Fan D; Lin X; Zhang F; Zhong W; Hu J; Chen Y; Cai Z; Zou Y; He X; Chen X; Lan P; Wu X
Cancer Sci; 2018 Feb; 109(2):354-362. PubMed ID: 29160937
[TBL] [Abstract][Full Text] [Related]
34. Natural Products That Target Cancer Stem Cells.
Moselhy J; Srinivasan S; Ankem MK; Damodaran C
Anticancer Res; 2015 Nov; 35(11):5773-88. PubMed ID: 26503998
[TBL] [Abstract][Full Text] [Related]
35. PTEN loss-mediated Akt activation increases the properties of cancer stem-like cell populations in prostate cancer.
Kim RJ; Bae E; Hong YK; Hong JY; Kim NK; Ahn HJ; Oh JJ; Park DS
Oncology; 2014; 87(5):270-9. PubMed ID: 25139413
[TBL] [Abstract][Full Text] [Related]
36. PTEN regulates BCRP/ABCG2 and the side population through the PI3K/Akt pathway in chronic myeloid leukemia.
Huang FF; Zhang L; Wu DS; Yuan XY; Yu YH; Zhao XL; Chen FP; Zeng H
PLoS One; 2014; 9(3):e88298. PubMed ID: 24603487
[TBL] [Abstract][Full Text] [Related]
37. [Role of PTEN protein in multidrug resistance of prostate cancer cells].
Sherbakova EA; Stromskaia TP; Rybalkina EIu; Kalita OV; Stavrovskaia AA
Mol Biol (Mosk); 2008; 42(3):487-93. PubMed ID: 18702307
[TBL] [Abstract][Full Text] [Related]
38. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation.
Li B; Lu Y; Yu L; Han X; Wang H; Mao J; Shen J; Wang B; Tang J; Li C; Song B
Chem Biol Interact; 2017 Nov; 277():33-42. PubMed ID: 28844858
[TBL] [Abstract][Full Text] [Related]
39. The Par-4/PTEN connection in tumor suppression.
Diaz-Meco MT; Abu-Baker S
Cell Cycle; 2009 Aug; 8(16):2518-22. PubMed ID: 19625770
[TBL] [Abstract][Full Text] [Related]
40. Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.
Mimeault M; Batra SK
Biochim Biophys Acta; 2011 Aug; 1816(1):25-37. PubMed ID: 21396984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
